Cargando…
Protective Effects of Sheng-Mai-San on Right Ventricular Dysfunction during Chronic Intermittent Hypoxia in Mice
Right ventricular (RV) dysfunction and failure contribute to the increasing morbidity and mortality of cardiovascular diseases; however, current treatment strategies are grossly inadequate. Sheng-Mai-San (SMS) has been used to treat heart diseases for hundreds of years in China, and its protective e...
Autores principales: | Chai, Cheng-Zhi, Mo, Wei-Lan, Zhuang, Xian-Fei, Kou, Jun-Ping, Yan, Yong-Qing, Yu, Bo-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814671/ https://www.ncbi.nlm.nih.gov/pubmed/27073402 http://dx.doi.org/10.1155/2016/4682786 |
Ejemplares similares
-
Sheng Mai San protects H9C2 cells against hyperglycemia-induced apoptosis
por: Pang, Bing, et al.
Publicado: (2019) -
ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress
por: Lu, Yanting, et al.
Publicado: (2021) -
Mechanism of new optimized Sheng-Mai-San Formula to regulate cardiomyocyte apoptosis through NMDAR pathway
por: Hou, Yazhu, et al.
Publicado: (2023) -
Extract of Sheng-Mai-San Ameliorates Myocardial Ischemia-Induced Heart Failure by Modulating Ca(2+)-Calcineurin-Mediated Drp1 Signaling Pathways
por: Yang, Ye, et al.
Publicado: (2017) -
The Protective Effect of Sheng Mai Yin on Diabetic Cardiomyopathy via NLRP3/Caspase-1 Pathway
por: Li, Jing-Ya, et al.
Publicado: (2022)